Atlas Trials

The Efficacy and Safety of Dapagliflozin in Improving Heart Failure in Dialysis Patients

Clinical trial NCT06365541 · UNKNOWN

Trial details

NCT number
NCT06365541
Sponsor
The People's Hospital of Gaozhou
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
The Efficacy and Safety of Dapagliflozin in Improving Heart Failure in Dialysis Patients
Start date
2024-03-01
Primary completion
2024-08-31
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.